2023 Awards 

During the 2023 Tandem Meetings, both ASTCT and CIBMTR celebrated great accomplishments in the field and recognize distinguished careers.

ASTCT Awards 

Lifetime Achievement Award: Dr. Fred Appelbaum

The Lifetime Achievement Award is presented to an eminent scientist or physician who has made continuing contributions to the BMT and cellular therapy fields through the advancement of knowledge via basic or clinical science. View past recipients

Public Service Award: Physicians, nurses, pharmacist, and advanced practice practitioners who continue to serve their patients in Ukraine.

Since February 25, 2022, physicians, nurses, pharmacist, and advanced practice practitioners continue to serve their patients in Ukraine and provide top quality care all while a war continues to wage in the background. This award will be accepted by Prof. Sergiy Klymenko, MD, PhD and Sybiryna Korenkova, MD on behalf of Ukraine medical professionals. 

The Public Service Award, presented at each year’s Annual Meeting, recognizes an individual who has advanced the interests of the BMT and cellular therapy field or has given special service to the patients and families that we serve. The honoree receives a plaque, along with expenses to attend the Annual Meeting. View past recipients.

New Investigator Awards: 

The New Investigator Awards are designed to encourage clinical or laboratory research by young investigators in the BMT and cellular therapy fields. The award — $50,000 per year, typically for two years — preferably is to be used to support the investigator’s salary for his or her research effort. Alternatively, the award may be used for direct support of research costs. Learn more.

Applications open through September 28, 2023.

CIBMTR Awards 

Distinguished Service Awardee: Prof. J Alejandro Madrigal 

The CIBMTR collaborates with the global scientific community to advance HCT and cellular therapy research worldwide. The purpose of the Distinguished Service Award is to recognize individuals who have made outstanding contributions to the CIBMTR's research mission in one or more of the following areas: Promoting HCT research and clinical care in developing countries, advancing the field despite unique challenges, expanding the availability of transplantation, disseminating research results to clinicians and patients to improve outcomes and quality of life, and collaboration with organizations to increase data exchange and research collaboration worldwide.